Drug Type CAR-T |
Synonyms CD19CAR T cell therapy Guangdong Zhaotai InVivo |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD19 positive Acute Lymphoblastic Leukemia | Phase 2 | CN | 01 May 2020 | |
Pre B-cell acute lymphoblastic leukemia | Phase 1 | CN | 18 Jan 2016 | |
Residual Neoplasm | Phase 1 | CN | 18 Jan 2016 | |
Treatment related acute myeloid leukaemia | Phase 1 | CN | 18 Jan 2016 | |
Leukemia | Phase 1 | CN | - |